The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Paclitaxel Injection Market Research Report 2025

Global Paclitaxel Injection Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1382010

No of Pages : 94

Ask Your Query

Synopsis

Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.

Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks.

The global Paclitaxel Injection market was valued at US$ 3384 million in 2023 and is anticipated to reach US$ 7130.2 million by 2030, witnessing a CAGR of 11.1% during the forecast period 2024-2030.

Global Paclitaxel Injection key players include Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Luye Pharma, etc. Global top five players hold a share about 80%.

Europe is the largest market, with a share about 25%, followed by North America and China, having a total share about 40 percent.

In terms of product, 5ml,30mg is the largest segment, with a share about 75%. And in terms of application, the largest application is Ovarian Cancer, followed by Breast Cancer, Cervical Cancer, Pancreatic Cancer.

This report aims to provide a comprehensive presentation of the global market for Paclitaxel Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel Injection.

Report Scope

The Paclitaxel Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Paclitaxel Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Paclitaxel Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Bristol-Myers Squibb
  • Celgene Corporation
  • Hospira
  • Biological E.
  • Taj Accura
  • Khandelwal Laboratories
  • Luye Pharma
  • Beijing Youcare
  • Beijing Union
  • Haiyao
  • Chuntch

Segment by Type

  • 5ml,30mg
  • 10ml,60mg
  • 16.7ml,100mg
  • 25ml,150mg
  • 50ml,300mg

Segment by Application

  • Ovarian Cancer
  • Breast Cancer
  • Cervical Cancer
  • Pancreatic Cancer
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Paclitaxel Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Paclitaxel Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Paclitaxel Injection Market Overview
1.1 Product Overview and Scope of Paclitaxel Injection
1.2 Paclitaxel Injection Segment by Type
1.2.1 Global Paclitaxel Injection Market Value Comparison by Type (2024-2030)
1.2.2 5ml,30mg
1.2.3 10ml,60mg
1.2.4 16.7ml,100mg
1.2.5 25ml,150mg
1.2.6 50ml,300mg
1.3 Paclitaxel Injection Segment by Application
1.3.1 Global Paclitaxel Injection Market Value by Application: (2024-2030)
1.3.2 Ovarian Cancer
1.3.3 Breast Cancer
1.3.4 Cervical Cancer
1.3.5 Pancreatic Cancer
1.3.6 Other
1.4 Global Paclitaxel Injection Market Size Estimates and Forecasts
1.4.1 Global Paclitaxel Injection Revenue 2019-2030
1.4.2 Global Paclitaxel Injection Sales 2019-2030
1.4.3 Global Paclitaxel Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Paclitaxel Injection Market Competition by Manufacturers
2.1 Global Paclitaxel Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Paclitaxel Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Paclitaxel Injection Average Price by Manufacturers (2019-2024)
2.4 Global Paclitaxel Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Paclitaxel Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Paclitaxel Injection, Product Type & Application
2.7 Paclitaxel Injection Market Competitive Situation and Trends
2.7.1 Paclitaxel Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Paclitaxel Injection Players Market Share by Revenue
2.7.3 Global Paclitaxel Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Paclitaxel Injection Retrospective Market Scenario by Region
3.1 Global Paclitaxel Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Paclitaxel Injection Global Paclitaxel Injection Sales by Region: 2019-2030
3.2.1 Global Paclitaxel Injection Sales by Region: 2019-2024
3.2.2 Global Paclitaxel Injection Sales by Region: 2025-2030
3.3 Global Paclitaxel Injection Global Paclitaxel Injection Revenue by Region: 2019-2030
3.3.1 Global Paclitaxel Injection Revenue by Region: 2019-2024
3.3.2 Global Paclitaxel Injection Revenue by Region: 2025-2030
3.4 North America Paclitaxel Injection Market Facts & Figures by Country
3.4.1 North America Paclitaxel Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Paclitaxel Injection Sales by Country (2019-2030)
3.4.3 North America Paclitaxel Injection Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Paclitaxel Injection Market Facts & Figures by Country
3.5.1 Europe Paclitaxel Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Paclitaxel Injection Sales by Country (2019-2030)
3.5.3 Europe Paclitaxel Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Paclitaxel Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Paclitaxel Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Paclitaxel Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Paclitaxel Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Paclitaxel Injection Market Facts & Figures by Country
3.7.1 Latin America Paclitaxel Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Paclitaxel Injection Sales by Country (2019-2030)
3.7.3 Latin America Paclitaxel Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Paclitaxel Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Paclitaxel Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Paclitaxel Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Paclitaxel Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Paclitaxel Injection Sales by Type (2019-2030)
4.1.1 Global Paclitaxel Injection Sales by Type (2019-2024)
4.1.2 Global Paclitaxel Injection Sales by Type (2025-2030)
4.1.3 Global Paclitaxel Injection Sales Market Share by Type (2019-2030)
4.2 Global Paclitaxel Injection Revenue by Type (2019-2030)
4.2.1 Global Paclitaxel Injection Revenue by Type (2019-2024)
4.2.2 Global Paclitaxel Injection Revenue by Type (2025-2030)
4.2.3 Global Paclitaxel Injection Revenue Market Share by Type (2019-2030)
4.3 Global Paclitaxel Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Paclitaxel Injection Sales by Application (2019-2030)
5.1.1 Global Paclitaxel Injection Sales by Application (2019-2024)
5.1.2 Global Paclitaxel Injection Sales by Application (2025-2030)
5.1.3 Global Paclitaxel Injection Sales Market Share by Application (2019-2030)
5.2 Global Paclitaxel Injection Revenue by Application (2019-2030)
5.2.1 Global Paclitaxel Injection Revenue by Application (2019-2024)
5.2.2 Global Paclitaxel Injection Revenue by Application (2025-2030)
5.2.3 Global Paclitaxel Injection Revenue Market Share by Application (2019-2030)
5.3 Global Paclitaxel Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Corporation Information
6.1.2 Bristol-Myers Squibb Description and Business Overview
6.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol-Myers Squibb Paclitaxel Injection Product Portfolio
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.2 Celgene Corporation
6.2.1 Celgene Corporation Corporation Information
6.2.2 Celgene Corporation Description and Business Overview
6.2.3 Celgene Corporation Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Celgene Corporation Paclitaxel Injection Product Portfolio
6.2.5 Celgene Corporation Recent Developments/Updates
6.3 Hospira
6.3.1 Hospira Corporation Information
6.3.2 Hospira Description and Business Overview
6.3.3 Hospira Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hospira Paclitaxel Injection Product Portfolio
6.3.5 Hospira Recent Developments/Updates
6.4 Biological E.
6.4.1 Biological E. Corporation Information
6.4.2 Biological E. Description and Business Overview
6.4.3 Biological E. Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biological E. Paclitaxel Injection Product Portfolio
6.4.5 Biological E. Recent Developments/Updates
6.5 Taj Accura
6.5.1 Taj Accura Corporation Information
6.5.2 Taj Accura Description and Business Overview
6.5.3 Taj Accura Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Taj Accura Paclitaxel Injection Product Portfolio
6.5.5 Taj Accura Recent Developments/Updates
6.6 Khandelwal Laboratories
6.6.1 Khandelwal Laboratories Corporation Information
6.6.2 Khandelwal Laboratories Description and Business Overview
6.6.3 Khandelwal Laboratories Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Khandelwal Laboratories Paclitaxel Injection Product Portfolio
6.6.5 Khandelwal Laboratories Recent Developments/Updates
6.7 Luye Pharma
6.6.1 Luye Pharma Corporation Information
6.6.2 Luye Pharma Description and Business Overview
6.6.3 Luye Pharma Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Luye Pharma Paclitaxel Injection Product Portfolio
6.7.5 Luye Pharma Recent Developments/Updates
6.8 Beijing Youcare
6.8.1 Beijing Youcare Corporation Information
6.8.2 Beijing Youcare Description and Business Overview
6.8.3 Beijing Youcare Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Beijing Youcare Paclitaxel Injection Product Portfolio
6.8.5 Beijing Youcare Recent Developments/Updates
6.9 Beijing Union
6.9.1 Beijing Union Corporation Information
6.9.2 Beijing Union Description and Business Overview
6.9.3 Beijing Union Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Beijing Union Paclitaxel Injection Product Portfolio
6.9.5 Beijing Union Recent Developments/Updates
6.10 Haiyao
6.10.1 Haiyao Corporation Information
6.10.2 Haiyao Description and Business Overview
6.10.3 Haiyao Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Haiyao Paclitaxel Injection Product Portfolio
6.10.5 Haiyao Recent Developments/Updates
6.11 Chuntch
6.11.1 Chuntch Corporation Information
6.11.2 Chuntch Paclitaxel Injection Description and Business Overview
6.11.3 Chuntch Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Chuntch Paclitaxel Injection Product Portfolio
6.11.5 Chuntch Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Paclitaxel Injection Industry Chain Analysis
7.2 Paclitaxel Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Paclitaxel Injection Production Mode & Process
7.4 Paclitaxel Injection Sales and Marketing
7.4.1 Paclitaxel Injection Sales Channels
7.4.2 Paclitaxel Injection Distributors
7.5 Paclitaxel Injection Customers
8 Paclitaxel Injection Market Dynamics
8.1 Paclitaxel Injection Industry Trends
8.2 Paclitaxel Injection Market Drivers
8.3 Paclitaxel Injection Market Challenges
8.4 Paclitaxel Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock